Medical Cannabis Can Help You Heal From Hepatitis C

Although Hepatitis C can be treated effectively, and may even clear up on its own, there is evidence that cannabis can help heal the liver. But it’s vague. A 2005 review of the medical literature concluded that cannabinoids “appear to be involved in several aspects of acute and chronic liver disease.” Another review from that year was both more upbeat and less precise: Cannabis, it said, presents “an exciting interventional landscape.”

Hepatitis C is a viral infection of the liver. Its symptoms are so mild that it is frequently undiagnosed—which is bad, because chronic Hepatitis C and lead to life-threatening conditions, such cirrhosis and liver cancer.

Hepatitis C is spread through blood, so the primary channels are having sex (particularly if you already have an STD) and sharing needles.

Newer Hep C drugs work well and have mild side effects, but the traditional treatment can cause anxiety, depression, nausea, and diarrhea. If you’re lucky, you’ll just get flu-like symptoms.

But one interesting vein of research shows that the primary benefit that cannabis provides hep C patients is not medical but motivational.

A study from 2006 observed that the primary risk group for Hepatitis C is illicit drug users are. Not to trade in stereotypes, but that population, practically by definition, is one that is marginal and has little support. Accordingly, it’s easy for them to drop out of treatment—particularly when that treatment can be physically and emotionally grueling.

The study concluded that cannabis can calm the ill effects of hep C treatment, much as it does the side effects of chemotherapy. But also, it just makes people feel better. And if they feel better and more hopeful about their lives, they’re more likely to continue treatment.

The study ends with this endearing attempt at nerd humor: “It may in fact be an ironical truth that those persons who contracted HCV [i.e. hep C] through a form of illicit drug use may be aided in ridding themselves of this, potentially fatal, virus by the use of another drug in addition to their HCV therapy.”

Enjoy this piece?

… then let us make a small request. AlterNet’s journalists work tirelessly to counter the traditional corporate media narrative. We’re here seven days a week, 365 days a year. And we’re proud to say that we’ve been bringing you the real, unfiltered news for 20 years—longer than any other progressive news site on the Internet.

It’s through the generosity of our supporters that we’re able to share with you all the underreported news you need to know. Independent journalism is increasingly imperiled; ads alone can’t pay our bills. AlterNet counts on readers like you to support our coverage. Did you enjoy content from David Cay Johnston, Common Dreams, Raw Story and Robert Reich? Opinion from Salon and Jim Hightower? Analysis by The Conversation? Then join the hundreds of readers who have supported AlterNet this year.

Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure AlterNet remains independent long into the future. Support progressive journalism with a one-time contribution to AlterNet, or click here to become a subscriber. Thank you. Click here to donate by check.